Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 113   

Articles published

JNJ 102.22 +0.18 (0.18%)
price chart
Better Dividend Stock: Johnson & Johnson vs. Eli Lilly and Company
Two companies that currently offer their investors big dividend checks right now are pharma giants Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ). Both of these companies produce billions in revenue and have been putting cash in their investors' ...
FDA Approval of Johnson & Johnson's Darzalex for Multiple Myeloma
On November 16, 2015, the US Food and Drug Administration approved Darzalex for multiple myeloma (or MM) patients who have received at least three prior lines of treatment.
Johnson & Johnson Announces $1.75 Million Donation to Save the Children to ...
NEW BRUNSWICK, N.J., Nov. 17, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced an expanded partnership with Save the Children to support children impacted by the Syrian refugee crisis and strengthen long-term resiliency in their ...
Market Update: Johnson & Johnson (NYSE:JNJ) - Johnson & Johnson ...  Jutia Group (press release) (blog)
A revolutionary new way to treat HIV could be on its way
Instead of a daily combination of pills, HIV could be treated with a shot once every one or two months. And the new treatment could be here in as little as in five years.
NJ's Johnson & Johnson may have amazing option for keeping HIV at bay  New Jersey 101.5 FM Radio
Johnson & Johnson HIV combination succeeds in mid-stage study  Reuters
Keeping employees healthy: an interview with Clare Sicklen, HR Director ...
Johnson & Johnson (J&J) was recently named Britain's Healthiest Company and recognised as having Britain's Healthiest Workforce.
Johnson & Johnson agrees to acquire clinical-stage biopharma
Johnson & Johnson announced Wednesday that it has agreed to acquire Novira Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of chronic hepatitis B. The acquisition includes Novira's ...
J&J to buy Bucks County biopharm firm focused on curing hepatitis B  Philadelphia Business Journal
Johnson & Johnson Announces Agreement To Acquire Novira Therapeutics, Inc.  FierceBiotech
Johnson & Johnson Names J3 Its Global Media Agency
A month after winning Johnson & Johnson's domestic media account, the company named UM's J3 as its global media agency, following a separate review, Adweek reports, picking up business from MEC and OMD in the process.
Johnson & Johnson consolidates global media into UM's J3  CampaignLive
Johnson & Johnson's Global Media Follows Its U.S. Biz to J3  Adweek
Johnson & Johnson (JNJ) Closes 0.72% Down on the Day for November 24
Dow Jones component Johnson & Johnson (JNJ) saw its stock move -0.72% to $102.03, representing a per-share move of $0.7377, on volume of 5.1 million shares for Tuesday.
Best Stocks: Johnson & Johnson (NYSE:JNJ), The Coca-Cola (NYSE:KO), Bank of ...
On Nov. 17, Johnson & Johnson (NYSE:JNJ) announced an expanded partnership with Save the Children to support children impacted by the Syrian refugee crisis and strengthen long-term resiliency in their communities.
Johnson & Johnson Enlists UNF Students For 3-D Printing Research, Development
Johnson & Johnson is asking University of North Florida students to help with researching and developing new 3-D printing technologies.